UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
ICVX holding history
Icosavax, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ICVX overviewAll 13F holders of ICVXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 7
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −256,869−100.0% | Sold out | Holders |
| Q4 2023 | 256,869 | $4.05M | <0.1% | +242,325+1,666.2% | Added | Holders |
| Q3 2023 | 14,544 | $112.7K | <0.1% | +7,183+97.6% | Added | Holders |
| Q2 2023 | 7,361 | $73.1K | <0.1% | +6,812+1,240.8% | Added | Holders |
| Q1 2023 | 549 | $3.18K | <0.1% | −2,549−82.3% | Reduced | Holders |
| Q4 2022 | 3,098 | $24.6K | <0.1% | −172,012−98.2% | Reduced | Holders |
| Q3 2022 | 175,110 | $553.0K | <0.1% | −15,378−8.1% | Reduced | Holders |
| Q2 2022 | 190,488 | $1.09M | <0.1% | +190,488 | New | Holders |